Emerging Therapeutic Potential of Cannabidiol (CBD) in Neurological Disorders: A Comprehensive Review
出版年份 2023 全文链接
标题
Emerging Therapeutic Potential of Cannabidiol (CBD) in Neurological Disorders: A Comprehensive Review
作者
关键词
-
出版物
BEHAVIOURAL NEUROLOGY
Volume 2023, Issue -, Pages 1-17
出版商
Hindawi Limited
发表日期
2023-10-13
DOI
10.1155/2023/8825358
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cannabidiol for the Treatment of Brain Disorders: Therapeutic Potential and Routes of Administration
- (2023) Grace Tsz Yan Yau et al. PHARMACEUTICAL RESEARCH
- Cannabidiol's neuroprotective properties and potential treatment of traumatic brain injuries
- (2023) Mackenzie M. Aychman et al. Frontiers in Neurology
- Real‐world data on cannabidiol treatment of various epilepsy subtypes: A retrospective, multicenter study
- (2023) Fabienne Kühne et al. Epilepsia Open
- Medical Cannabis in the Treatment of Parkinson’s Disease
- (2023) Traci S. Aladeen et al. CLINICAL NEUROPHARMACOLOGY
- Efficacy of cannabinoids in neurodevelopmental and neuropsychiatric disorders among children and adolescents: a systematic review
- (2023) Lauren J. Rice et al. EUROPEAN CHILD & ADOLESCENT PSYCHIATRY
- A Comprehensive Review of the Pharmacological Importance of Dietary Flavonoids as Hepatoprotective Agents
- (2023) Gajender et al. Evidence-based Complementary and Alternative Medicine
- The Polypharmacological Effects of Cannabidiol
- (2023) Jorge Castillo-Arellano et al. MOLECULES
- Medicinal Cannabis for Paediatric Developmental, Behavioural and Mental Health Disorders
- (2023) Daryl Efron et al. International Journal of Environmental Research and Public Health
- Epilepsy in Dravet Syndrome—Current and Future Therapeutic Opportunities
- (2023) Chao Gao et al. Journal of Clinical Medicine
- Cannabis update: Anxiety disorders and post-traumatic stress disorder
- (2023) Amy L. Haycraft Journal of the American Association of Nurse Practitioners
- Non-Psychoactive Cannabinoid Modulation of Nociception and Inflammation Associated with a Rat Model of Pulpitis
- (2023) Elana Y. Laks et al. Biomolecules
- Exploring the Therapeutic Potential of Cannabinoid Receptor Antagonists in Inflammation, Diabetes Mellitus, and Obesity
- (2023) Alexandru Vasincu et al. Biomedicines
- Retrospective chart review study of use of cannabidiol (CBD) independent of concomitant clobazam use in patients with Lennox-Gastaut syndrome or Dravet syndrome
- (2023) Rima Nabbout et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Pharmacokinetics, efficacy, and safety of cannabidiol in dogs: an update of current knowledge
- (2023) Alessandra Di Salvo et al. Frontiers in Veterinary Science
- A narrative review of molecular mechanism and therapeutic effect of cannabidiol (CBD)
- (2022) Jiangling Peng et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Low-Dose Delta-9-Tetrahydrocannabinol as Beneficial Treatment for Aged APP/PS1 Mice
- (2022) Yanhong Wang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cannabidiol (CBD) Dosing: Plasma Pharmacokinetics and Effects on Accumulation in Skeletal Muscle, Liver and Adipose Tissue
- (2022) Robert B. Child et al. Nutrients
- Cannabidiol (CBD) in the Self-Treatment of Depression-Exploratory Study and a New Phenomenon of Concern for Psychiatrists
- (2022) Gniewko Wieckiewicz et al. Frontiers in Psychiatry
- Neuroprotection of Cannabidiol, Its Synthetic Derivatives and Combination Preparations against Microglia-Mediated Neuroinflammation in Neurological Disorders
- (2022) Muhammad Yousaf et al. MOLECULES
- Tetrahydrocannabinol and cannabidiol medicines for chronic pain and mental health conditions
- (2022) Jeremy D. Henson et al. INFLAMMOPHARMACOLOGY
- Potential Effect of DPP-4 Inhibitors Towards Hepatic Diseases and Associated Glucose Intolerance
- (2022) Ashwani Sharma et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- Cannabidiol for neurodegenerative disorders: A comprehensive review
- (2022) Sukanya Bhunia et al. Frontiers in Pharmacology
- The Therapeutic Potential of the Endocannabinoid System in Age-Related Diseases
- (2022) Ivona Maria Tudorancea et al. Biomedicines
- Managing Chronic Neuropathic Pain: Recent Advances and New Challenges
- (2022) Namrata Hange et al. Neurology Research International
- Antidepressive-Like Effect of Aegle marmelos Leaf Extract in Chronic Unpredictable Mild Stress-Induced Depression-Like Behaviour in Rats
- (2022) Ashwani Sharma et al. Biomed Research International
- Effects of SativexⓇ on cognitive function in patients with multiple sclerosis: A systematic review and meta-analysis
- (2022) Igor Dykukha et al. Multiple Sclerosis and Related Disorders
- Cannabidiol as a Therapeutic Target: Evidence of its Neuroprotective and Neuromodulatory Function in Parkinson’s Disease
- (2021) Felipe Patricio et al. Frontiers in Pharmacology
- Cannabidiol in the Treatment of Epilepsy
- (2021) Randi von Wrede et al. CLINICAL DRUG INVESTIGATION
- Cannabidiol as a Potential Treatment for Anxiety and Mood Disorders: Molecular Targets and Epigenetic Insights from Preclinical Research
- (2021) Philippe A. Melas et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cannabidiol in Neurological and Neoplastic Diseases: Latest Developments on the Molecular Mechanism of Action
- (2021) Marcin Ożarowski et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Role of Cannabidiol in the Therapeutic Intervention for Substance Use Disorders
- (2021) Francisco Navarrete et al. Frontiers in Pharmacology
- Cannabinoid Formulations and Delivery Systems: Current and Future Options to Treat Pain
- (2021) Barbara Stella et al. DRUGS
- “Is medical cannabis safe for my patients?” A practical review of cannabis safety considerations
- (2021) Caroline A. MacCallum et al. European Journal of Internal Medicine
- The Endocannabinoid System: A Potential Target for the Treatment of Various Diseases
- (2021) Henry Lowe et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Neuroprotective and Symptomatic Effects of Cannabidiol in an Animal Model of Parkinson’s Disease
- (2021) Claudio Giuliano et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Link between Cannabis Use, Immune System, and Viral Infections
- (2021) Sanjay B. Maggirwar et al. Viruses-Basel
- The Impact of THC and CBD in Schizophrenia: A Systematic Review
- (2021) Saeed Ahmed et al. Frontiers in Psychiatry
- Can Cannabidiol Affect the Efficacy of Chemotherapy and Epigenetic Treatments in Cancer?
- (2021) Courtney Griffiths et al. Biomolecules
- Practical considerations for testing the effects of cannabidiol on human anxiety
- (2021) Ellen W. Leen-Feldner et al. JOURNAL OF ANXIETY DISORDERS
- Long‐term cannabidiol treatment for seizures in patients with tuberous sclerosis complex: An open‐label extension trial
- (2021) Elizabeth A. Thiele et al. EPILEPSIA
- Enhancing Endocannabinoid Control of Stress with Cannabidiol
- (2021) Jeremy D. Henson et al. Journal of Clinical Medicine
- A Guide to Targeting the Endocannabinoid System in Drug Design
- (2020) Adam Stasiulewicz et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Effects of Chronic Cannabidiol Treatment in the Rat Chronic Unpredictable Mild Stress Model of Depression
- (2020) Zsolt Gáll et al. Biomolecules
- Migraine Frequency Decrease Following Prolonged Medical Cannabis Treatment: A Cross-Sectional Study
- (2020) Joshua Aviram et al. Brain Sciences
- Cannabinoids and Cannabinoid Receptors: The Story so Far
- (2020) Fred Shahbazi et al. iScience
- Cannabidiol in conjunction with clobazam: analysis of four randomized controlled trials
- (2020) Boudewijn Gunning et al. ACTA NEUROLOGICA SCANDINAVICA
- Cannabidiol Treatment for Refractory Epilepsies in Pediatrics
- (2020) Umberto Raucci et al. Frontiers in Pharmacology
- Cannabidiol for Pain Treatment: Focus on Pharmacology and Mechanism of Action
- (2020) Jakub Mlost et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Comprehensive Review on Alzheimer’s Disease: Causes and Treatment
- (2020) Zeinab Breijyeh et al. MOLECULES
- Crosstalk between the transcriptional regulation of dopamine D2 and cannabinoid CB1 receptors in schizophrenia: Analyses in patients and in perinatal Δ9-tetrahydrocannabinol-exposed rats
- (2020) Martina Di Bartolomeo et al. PHARMACOLOGICAL RESEARCH
- Add-On Cannabidiol Treatment for Drug-Resistant Seizures in Tuberous Sclerosis Complex
- (2020) Elizabeth A. Thiele et al. JAMA Neurology
- Cannabidiol: A Potential New Alternative for the Treatment of Anxiety, Depression, and Psychotic Disorders
- (2020) María S. García-Gutiérrez et al. Biomolecules
- Use of Cannabidiol in the Treatment of Epilepsy: Efficacy and Security in Clinical Trials
- (2019) Serena Silvestro et al. MOLECULES
- Potential Adverse Drug Events and Drug–Drug Interactions with Medical and Consumer Cannabidiol (CBD) Use
- (2019) Joshua D. Brown et al. Journal of Clinical Medicine
- The Potential of Cannabidiol as a Treatment for Psychosis and Addiction: Who Benefits Most? A Systematic Review
- (2019) Albert Batalla et al. Journal of Clinical Medicine
- Pharmacokinetics of oral and intravenous cannabidiol and its antidepressant-like effects in chronic mild stress mouse model
- (2019) Chen Xu et al. ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY
- Clinicians’ Guide to Cannabidiol and Hemp Oils
- (2019) Harrison J. VanDolah et al. MAYO CLINIC PROCEEDINGS
- Epigenetic effects mediated by antiepileptic drugs and their potential application
- (2019) Fan-Cheng Kong et al. Current Neuropharmacology
- Coadministered cannabidiol and clobazam: Preclinical evidence for both pharmacodynamic and pharmacokinetic interactions
- (2019) Lyndsey L. Anderson et al. EPILEPSIA
- Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial
- (2018) Philip McGuire et al. AMERICAN JOURNAL OF PSYCHIATRY
- Endocannabinoid system, Stress and HPA axis
- (2018) Vincenzo Micale et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System
- (2018) et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial
- (2018) Elizabeth A Thiele et al. LANCET
- Cannabidiol improves frequency and severity of seizures and reduces adverse events in an open-label add-on prospective study
- (2018) Jerzy P. Szaflarski et al. EPILEPSY & BEHAVIOR
- Cannabidiol modulates serotonergic transmission and prevents allodynia and anxiety-like behavior in a model of neuropathic pain
- (2018) Danilo De Gregorio et al. PAIN
- Social Determinants of Mental Health: Where We Are and Where We Need to Go
- (2018) Margarita Alegría et al. Current Psychiatry Reports
- Cannabidiol presents an inverted U-shaped dose-response curve in a simulated public speaking test
- (2018) Ila M. Linares et al. REVISTA BRASILEIRA DE PSIQUIATRIA
- Cannabis sativa L. and Nonpsychoactive Cannabinoids: Their Chemistry and Role against Oxidative Stress, Inflammation, and Cancer
- (2018) Federica Pellati et al. Biomed Research International
- Peripubertal cannabidiol treatment rescues behavioral and neurochemical abnormalities in the MAM model of schizophrenia
- (2018) Tibor Stark et al. NEUROPHARMACOLOGY
- The effects of cannabidiol on persecutory ideation and anxiety in a high trait paranoid group
- (2017) Harneet Hundal et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
- (2017) Orrin Devinsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cannabidiol Treatment for Refractory Seizures in Sturge-Weber Syndrome
- (2017) Emma H. Kaplan et al. PEDIATRIC NEUROLOGY
- Cannabidiol: State of the art and new challenges for therapeutic applications
- (2017) Simona Pisanti et al. PHARMACOLOGY & THERAPEUTICS
- Inverted U-Shaped Dose-Response Curve of the Anxiolytic Effect of Cannabidiol during Public Speaking in Real Life
- (2017) Antonio W. Zuardi et al. Frontiers in Pharmacology
- In vivo Evidence for Therapeutic Properties of Cannabidiol (CBD) for Alzheimer's Disease
- (2017) Georgia Watt et al. Frontiers in Pharmacology
- Anandamide reverses depressive-like behavior, neurochemical abnormalities and oxidative-stress parameters in streptozotocin-diabetic rats: Role of CB1 receptors
- (2016) Helen de Morais et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Current Status and Prospects for Cannabidiol Preparations as New Therapeutic Agents
- (2016) Pius S. Fasinu et al. PHARMACOTHERAPY
- Cannabidiol is a partial agonist at dopamine D2High receptors, predicting its antipsychotic clinical dose
- (2016) P Seeman Translational Psychiatry
- A Personal Retrospective: Elevating Anandamide (AEA) by Targeting Fatty Acid Amide Hydrolase (FAAH) and the Fatty Acid Binding Proteins (FABPs)
- (2016) Dale G. Deutsch Frontiers in Pharmacology
- Cannabidiol as potential treatment in refractory pediatric epilepsy
- (2015) Maria Chiara Paolino et al. Expert Review of Neurotherapeutics
- Cannabidiol as a Potential Treatment for Anxiety Disorders
- (2015) Esther M. Blessing et al. Neurotherapeutics
- Molecular Targets of Cannabidiol in Neurological Disorders
- (2015) Clementino Ibeas Bih et al. Neurotherapeutics
- 2-AG promotes the expression of conditioned fear via cannabinoid receptor type 1 on GABAergic neurons
- (2015) Alvaro Llorente-Berzal et al. PSYCHOPHARMACOLOGY
- Cannabidiol as potential treatment in refractory pediatric epilepsy
- (2015) Maria Chiara Paolino et al. Expert Review of Neurotherapeutics
- Cannabinoid receptor type 1 receptors on GABAergic vs. glutamatergic neurons differentially gate sex-dependent social interest in mice
- (2014) Ana Luisa B. Terzian et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Nabiximols as an Agonist Replacement Therapy During Cannabis Withdrawal
- (2014) David J. Allsop et al. JAMA Psychiatry
- Cannabidiol reduces cigarette consumption in tobacco smokers: Preliminary findings
- (2013) Celia J.A. Morgan et al. ADDICTIVE BEHAVIORS
- Modulating the endocannabinoid system in human health and disease - successes and failures
- (2013) Pál Pacher et al. FEBS Journal
- Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?
- (2012) Javier Fernández-Ruiz et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Endocannabinoid system and mood disorders: Priming a target for new therapies
- (2012) Vincenzo Micale et al. PHARMACOLOGY & THERAPEUTICS
- Endocannabinoids in nervous system health and disease: the big picture in a nutshell
- (2012) S. D. Skaper et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Neurological diseases and pain
- (2011) David Borsook BRAIN
- Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease
- (2011) Susan Duty et al. BRITISH JOURNAL OF PHARMACOLOGY
- The Endogenous Cannabinoid 2-Arachidonoylglycerol Is Intravenously Self-Administered by Squirrel Monkeys
- (2011) Z. Justinova et al. JOURNAL OF NEUROSCIENCE
- Cannabidiol-treated Rats Exhibited Higher Motor Score After Cryogenic Spinal Cord Injury
- (2011) Marcelo Kwiatkoski et al. NEUROTOXICITY RESEARCH
- Huntington's disease: a clinical review
- (2011) Raymund A.C. Roos Orphanet Journal of Rare Diseases
- The Dopamine and Cannabinoid Interaction in the Modulation of Emotions and Cognition: Assessing the Role of Cannabinoid CB1 Receptor in Neurons Expressing Dopamine D1 Receptors
- (2011) Ana Luisa Terzian et al. Frontiers in Behavioral Neuroscience
- Treatment strategies for tics in Tourette syndrome
- (2010) Clare M. Eddy et al. Therapeutic Advances in Neurological Disorders
- Multiple system atrophy: current and future approaches to management
- (2010) Olivier Flabeau et al. Therapeutic Advances in Neurological Disorders
- Cannabidiol for the treatment of psychosis in Parkinson’s disease
- (2008) AW Zuardi et al. JOURNAL OF PSYCHOPHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started